About this trial
The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are:
1. Are the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) after pancreatic cancer of different etiologies the same? 2. Are alterations in endocrine and exdocrine secretory function in patients with pancreatic surgery associated with all-round outcomes? All patients with pancreatic surgery have been given the standardized treatment for the condition.
The reasearchers will summarize the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) during different surgical procedures to explore the association between alternations in endocrine and exdocrine secrectory function and all-round outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
patients with pancreatic cancer after pancreatic surgery
Trial design
Cohort
Prospective
Treatments tested in this trial
All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data.
Diagnostic testAll enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data.
Treatment groups
Trial outcomes
Primary outcomes
Number of Participants Who developed glucose metabolic disorders(pre-diabetes and diabetes mellitus)
The diagnosis of glucose disorders should be made applying criteria of the American Diabetes Association.
Secondary outcomes
Overall Survival
Disease-Free Survival
Sponsors and contacts
Click on the lead sponsor to view all of their trials.